The Pharmaceutical Journal Vol 264 No 7102p970
June 24, 2000 Products
Responsibility for sales, marketing and medical inquires for Hycamtin (topotecan hydrochloride) 4mg vials will be transferred from Smithkline Beecham Pharmaceuticals to Merck Pharmaceuticals UK from June 26. The product will continue to be in the livery of Smithkline Beecham. All orders from this date should be sent to Merck Pharmaceuticals UK, Customer Service Centre, Hunter Boulevard, Magna Park, Lutterworth, Leicestershire LE17 4XN (tel 01455 550911, fax 01455 558586).
Citation: The Pharmaceutical Journal URI: 20001988
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com